Part 5/13:
Developed nations exercised what has been termed "vaccine nationalism," leveraging their financial resources to secure priority access. Pharmaceutical companies, supported by investments from the West and Asia, prioritized fulfilling orders from richer countries, leaving poorer nations at the back of the queue. This imbalance has led to devastating consequences, allowing the Delta variant and subsequent mutations to propagate in under-vaccinated populations.